Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...

Princess Kate Middleton honored late cancer patient Liz Hatton for International Women’s Day on Saturday, March 8 ...

AstraZeneca's Imfinzi perioperative regimen improved event-free survival in gastric and GEJ cancer. The trial showed a strong ...

An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

The NHS should follow Denmark and offer chemotherapy at home, a leading MP has said. Sir Geoffrey Clifton-Brown, the Tory MP who chairs the public accounts committee, urged the health service to learn ...

Tislelizumab plus chemotherapy is now FDA-approved for metastatic esophageal squamous cell carcinoma with a tumor PD-L1 ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...